Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by death of motor neurons in the cortex and spinal cord. This loss causes progressive weakness amyotrophy. To date, median duration survival patients with ALS, from first symptoms to death, estimated be 36 months. Currently treatment limited two options: riluzole which prolongs for few months edaravone availa...
